Inditrade Cap.

Q2 FY21 Earnings Call Analysis

Finance

Full Stock Analysis
fundraise: No informationcapex: No informationrevenue: Category 4margin: Category 3orderbook: No information
💰

fundraise

Any current/future new fundraising through debt or equity?

- Inditrade Capital Limited has maintained an extremely risk-averse and conservative policy regarding leverage for over a year. - As of June 30, 2021, total debt stood at ₹185 crore with a debt-equity ratio of 0.92. - No additional leveraging was done during the current quarter (Q1 FY22). - The company is cautious about hiring and costs amid uncertainties like COVID variants. - There is no explicit mention of new fundraising plans via debt or equity in the transcript. - Management emphasizes managing cost and right-sizing, suggesting prudence in financial moves. - Future disbursements and expansions are contingent on economic conditions and regulatory guidelines. - Therefore, as per the provided transcript, no current or definite plans for debt or equity fundraising have been announced.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

The transcript on page 10 and surrounding pages does not explicitly mention any current or future capex, capital investments, or strategic investments by Inditrade Capital Limited. However, some related points can be inferred: - The company is cautiously managing manpower and costs, e.g., right sizing in Microfinance due to reduced book size. - They are expanding business in select geographies cautiously, e.g., potential expansion of Boonbox into Chhattisgarh with limited hiring. - Insurance broking business is growing with plans for launching an online insurance platform (IRDA approved), but no big marketing spend planned; mainly a facilitation tool for partners. - No explicit mention of any major capital expenditure or strategic investments during or after Q1 FY22. - Focus is on measured growth and risk aversion amid COVID uncertainties; new business ramp-up and cost management prioritized over expansion investments. In summary, no clear capex or strategic investment plans were disclosed in the call transcript.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Optimistic about business performance in Q2 and the rest of the year, assuming no further COVID waves. - Microfinance and MSME segments are showing strong signs of recovery with collection rates improving (93-96% in July). - Resumption and growth expected in lending activities across segments including Microfinance, MSME, and Agri-finance. - Boonbox and Scalerator businesses recovering; Scalerator turned profitable in July, with positive outlook for August. - MSME focus shifted to wholesale and manufacturing sectors, which are relatively insulated from lockdowns, aiding stable collections and growth. - Microloan disbursals expected to resume cautiously, initially at 5-6 crores per month, potentially increasing to 10-12 crores monthly, subject to RBI guidelines and pandemic conditions. - Cautious hiring planned only for critical needs, especially for Boonbox expansion in select geographies (e.g., Chhattisgarh). - Cost management prioritized to ensure profitability despite fluctuating business volumes.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- The business is cautiously optimistic about growth, with expectations improving as COVID restrictions ease. - Microfinance disbursals are expected to rise from about ₹5-6 crore per month to potentially ₹10-12 crore monthly, subject to RBI guidelines and pandemic developments. - Boonbox and Scalerator businesses are rapidly recovering, with Scalerator breaking even in July and Boonbox expecting good business from August onwards. - MSME lending strategy has shifted to wholesale and manufacturing sectors, insulated from COVID lockdowns, showing strong collections (~96% in July). - The company is focused on cost management, having right-sized certain segments like Microfinance to align manpower with book size. - Provisions were significant in the past quarter, and recoveries are expected going forward, particularly in Q2 and beyond. - Overall profits are currently small but expected to grow gradually as business normalizes and economies reopen.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

The transcript provided does not explicitly mention current or expected orderbook or pending orders for Inditrade Capital Limited. However, insights related to business outlook and activities include: - Lending book stood at Rs. 333.27 crore as of June 30, 2021. - Microfinance book was reduced due to COVID impact but disbursals have resumed with Rs. 18 crore in the last month and expected Rs. 50 crore in current month. - MSME finance is picking up, with a strategic shift from retail to wholesale lending. - Boonbox business (rural e-Commerce) was affected during lockdown but normalized and showing good business from August. - Scalerator broke even and started making profits again in July; August looks good. - Collections in Microfinance and MSME improved significantly in July (~93-96% recovery). - Business recovery is contingent on COVID situation and RBI guidelines, making precise orderbook forecasting uncertain.